INTERNATIONAL GUIDELINES FOR THE SELECTION OF LUNG TRANSPLANT CANDIDATES
The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
More than 6400 lung transplants have been performed since the first successful operations in the early 1980s. (1) Lung transplant programs now exist in many countries. Internationally, the number of donor organs available is far fewer than the number of patients with end-stage lung disease. Because of this many candidates die on the waiting list and the average wait to receive a donor organ may approach two years. (2) Overall survivals are between 60 and 65 per cent at two years and approximately 40 per cent at five years. (1) Considering the resource limitations and the importance of assuring optimum outcomes, we believe that international guidelines for selection of appropriate candidates for lung transplant will ensure a fair distribution of donor organs. Transplant physicians and surgeons representing the International Society of Heart and Lung Transplantation, the American Society of Transplant Physicians, the American Thoracic Society, the European Respiratory Society, and the Thoracic Society of Australia and New Zealand have agreed on the information in the following document as acceptable guidelines for candidates for lung transplantation. Our aim is that this document will assist physicians throughout the world who are treating patients with pulmonary diseases to identify potential candidates for lung transplantation. This document is divided into two sections. The first describes general health guidelines which all candidates for lung transplantation should meet; the second describes disease specific exercise or lung function criteria which are generally felt to identify patients whose poor prognosis from their underlying disease justify transplantation. Candidates for either live donor organs or cadaver donor organs should meet the same selection criteria. In all cases it must be remembered that these guidelines are a general statement and that individual patients might have specific circumstances which do not meet all guidelines yet would be acceptable transplant candidates. Lung transplantation remains a developing field within pulmonary medicine and thoracic surgery. It is anticipated that with increasing experience and knowledge the state of the art will change and these guidelines will require review and modification. GENERAL GUIDANCE FOR CANDIDATE SELECTION FOR LUNG TRANSPLANTATION Physicians evaluating patients for lung transplantation should ensure that the patient has received or is receiving maximum, optimal medical therapy for his disease but nevertheless has declining function. In general candidates should have chronic disease for which no further medical or surgical therapy is available and survival is limited; lung transplantation is rarely an option for acutely, critically ill patients. Comorbid medical conditions should also be optimally treated in transplant candidates and routine preventive medicine measures (such as mammograms, Pap smears, and colon cancer screening) be completed where appropriate. Older patients have a significantly worse survival than younger patients (1). The following guidelines are suggested. Age limits: Heart-lung transplants ∼ 55 years Single lung transplants ∼ 65 years Bilateral lung transplants ∼ 60 years GENERAL MEDICAL CONDITIONS WHICH IMPACT ON ELIGIBILITY FOR LUNG TRANSPLANTATION The following are a list of general medical conditions which are felt to impact on the long-term outcome of lung transplant recipients. Medical or psychosocial treatment to address these issues should be instituted when appropriate in patients who do not currently, but may ultimately, meet the criteria for lung transplantation. However, in most cases, referral should not be delayed while patients are undergoing corrective treatment. Other medical conditions which, when they have not resulted in organ damage, are generally acceptable in candidates for lung transplantation-e.g., systemic hypertension, diabetes mellitus, peptic ulcer disease, should also be optimally treated and well-controlled. In the presence of any comorbid medical condition with the potential for end organ damage, a careful search should be made for evidence of organ dysfunction. Symptomatic osteoporosis is a relative contraindication to transplantation and the potential risk to acceptable long term outcome should be assessed on a case by case basis. (3) symptomatic and asymptomatic significant disease requires treatment which should be initiated prior to transplant. Patients should be fully investigated and followed by appropriate objective measures, i.e. bone densitometry. Severe musculoskeletal disease affecting the thorax, e.g., kyphoscoliosis, is a relative contraindication and progressive neuromuscular disease is an absolute contraindication to lung transplantation. Current use of corticosteroids is not a contraindication to transplantation; however, all attempts to discontinue these drugs or at least reduce the dose to≤20 mg. per day prednisolone or prednisone should be made. (4) Nutritional issue
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This trend reflects the expansion of acceptable donors and candidates made possible by clinical and scientific advances. Far fewer absolute contraindications for lung transplant candidacy exist now, compared to the time of publication of prior versions of this document, making the selection of candidates even more complex.”
From Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation. (2021) · cites this paper as [3]
In the citing paper
“Far fewer absolute contraindications for lung transplant candidacy exist now, compared to the time of publication of prior versions of this document”
From Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation. (2021) · cites this paper as [3]
Citations
Cites
J Heart Lung Transplant 2021;40(4).
(2021) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2021.04.002 · Cited by 6,665
D'Alonzo, G. E., Barst, R. J., Ayres, S. M., Bergofsky, E. H., Brundage, B. H., Detre, K. M., Fishman, A. P., Goldring, R. M., Groves, B. M., Kernis, J. T., et al. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-5-343 · Cited by 3,501
Barst, R. J., Rubin, L. J., Long, W. A., McGoon, M. D., Rich, S., Badesch, D. B., Groves, B. M., Tapson, V. F., Bourge, R. C., Brundage, B. H., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199602013340504 · Cited by 2,698
Connors, A. F., Dawson, N. V., Thomas, C., Harrell, F. E., Desbiens, N., Fulkerson, W. J., Kussin, P., Bellamy, P., Goldman, L., & Knaus, W. A. (1996) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.154.4.8887592 · Cited by 1,393
Prediction of mortality in patients with cystic fibrosis
Kerem, E., Reisman, J., Corey, M., Canny, G. J., & Levison, H. (1992) · New England Journal of Medicine · doi:10.1056/nejm199204303261804 · Cited by 993
Cooper, J. D., Patterson, G. A., Sundaresan, R. S., Trulock, E. P., Yusen, R. D., Pohl, M. S., & Lefrak, S. S. (1996) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(96)70147-2 · Cited by 518
Hopkins, W. E., Ochoa, L. L., Richardson, G., & Trulock, E. P. (1996) · PubMed · Cited by 444
Raghu, G., Depaso, W. J., Cain, K., Hammar, S. P., Wetzel, C. E., Dreis, D. F., Hutchinson, J., Pardee, N. E., & Winterbauer, R. H. (1991) · American Review of Respiratory Disease · doi:10.1164/ajrccm/144.2.291 · Cited by 414
Jego, P. (1996) · La Revue de Médecine Interne · doi:10.1016/0248-8663(96)83752-0 · Cited by 409
Nutritional status and mortality in chronic obstructive pulmonary disease.
Gray-Donald, K., Gibbons, L., Shapiro, S. H., Macklem, P. T., & Martin, J. G. (1996) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.153.3.8630580 · Cited by 398
Research works printed but not linked: 5
- Hosenpud, 1997, J Heart Lung Transplant, 16, 691
- Sharples, 1993, J Heart Lung Transplant, 12, 669
- Grady, 1996, J Heart Lung Transplant, 15, 863
- Bando, 1995, J Heart Lung Transplant, 14, 692
- Hopkins, 1996, J Heart Lung Transplant, 15, 100
Cited by
Vestbo, J., Hurd, S. S., Agustí, A. G., Jones, P. W., Vogelmeier, C., Anzueto, A., Barnes, P. J., Fabbri, L. M., Martinez, F. J., Nishimura, M., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201204-0596pp · Cited by 15,983
PAUWELS, R. A., BUIST, A. S., CALVERLEY, P. M. A., JENKINS, C. R., & HURD, S. S. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.163.5.2101039 · Cited by 6,587
Rabe, K. F., Hurd, S., Anzueto, A., Barnes, P. J., Buist, S. A., Calverley, P., Fukuchi, Y., Jenkins, C., Rodriguez-Roisin, R., van Weel, C., et al. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200703-456so · Cited by 4,925
Celli, B. R., MacNee, W., Agusti, A., Anzueto, A., Berg, B., Buist, A. S., Calverley, P. M. A., Chavannes, N., Dillard, T., Fahy, B., et al. (2004) · European Respiratory Journal · doi:10.1183/09031936.04.00014304 · Cited by 4,421
EASL Recommendations on Treatment of Hepatitis C 2018
Pawlotsky, J.-M., Negro, F., Aghemo, A., Berenguer, M., Dalgard, O., Dusheiko, G., Marra, F., Puoti, M., & Wedemeyer, H. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.03.026 · Cited by 2,827
Metadata
- Authors
- Maurer, J. R., Frost, A. E., Estenne, M., Higenbottam, T., & Glanville, A. R.
- Affiliations
- American Society of Transplantation (US)
- Venue
- Transplantation
- Published
- 1998-10
- Volume
- 66
- Issue
- 7
- Pages
- 951-956
- ISSN
- 0041-1337 (ISSN-L)
- OpenAlex
- W1972718711
- Semantic Scholar
- a7bc9ba3027b187f680e5aa329f5f4013136f49f
- Cited by
- 562
- References
- 39
- Citations by year
- 2025: 7 · 2024: 2 · 2023: 6 · 2022: 7 · 2021: 12 · 2020: 15 · 2019: 8 · 2018: 10 · 2017: 14 · 2016: 10 · 2015: 17 · 2014: 34 · 2013: 21 · 2012: 25
- FWCI
- 18.12
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Transplantation (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Surgery › Transplantation: Methods and Outcomes
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Organ Donation and Transplantation
- Health Sciences › Medicine › Surgery › Organ Transplantation Techniques and Outcomes
- Keywords
- lung transplantation, transplant candidate selection, end-stage lung disease, organ allocation, exercise capacity, lung function, age limits, comorbidities, International Society for Heart and Lung Transplantation, international consensus guidelines, waitlist mortality, donor shortage, elderly patients, chronic obstructive pulmonary disease, interstitial lung disease
- MeSH terms
- Humans, Lung Transplantation, Patient Selection
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: INTERNATIONAL GUIDELINES FOR THE SELECTION OF LUNG TRANSPLANT CANDIDATES. https://app.cochat.ai/papers/10.1097/00007890-199810150-00033
- The paper
- Maurer, J. R., Frost, A. E., Estenne, M., Higenbottam, T., & Glanville, A. R. (1998). INTERNATIONAL GUIDELINES FOR THE SELECTION OF LUNG TRANSPLANT CANDIDATES. Transplantation. https://doi.org/10.1097/00007890-199810150-00033
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.